Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells
Author:
Affiliation:
1. School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China
2. School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Guangzhou 510006, China
Funder
Guangzhou Science and Technology Program key projects
National Natural Science Foundation of China
Guangdong Science and Technology Project
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00976
Reference42 articles.
1. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer
2. Disease Burden of Hepatocellular Carcinoma: A Global Perspective
3. Synthesis and anti-metastasis activities of norcantharidin-conjugated carboxymethyl chitosan as a novel drug delivery system
4. Studies on anti-hepatocarcinoma effect, pharmacokinetics and tissue distribution of carboxymethyl chitosan based norcantharidin conjugates
5. Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mesenchymal stem cell-derived exosomes as cell free nanotherapeutics and nanocarriers;Nanomedicine: Nanotechnology, Biology and Medicine;2024-10
2. Exosomes improved the in vitro anti-melanoma efficacy of dihydroartemisinin;Journal of Drug Delivery Science and Technology;2024-09
3. Recent advances in nano-based drug delivery systems for treatment of liver cancer;Journal of Pharmaceutical Sciences;2024-08
4. The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics;MedComm;2024-07-28
5. The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma;Frontiers in Immunology;2024-05-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3